Annuaire du CSM
Dr Vincent PICCO
Chargé de Recherche - Équipe Cellules Souches et Tumeurs du CerveauTel. +377 97 77 44 15
Email : [javascript protected email address]
CV 2020_ENG
Thèmes de recherche développés
Projets transversaux Biologie Marine - Biologie Médicale :
- Signalisation intracellulaire en réponse au stress, approches comparatives cnidaires/mammifères.
- Bio-prospection marine et nouveaux composés anti-cancer.
Publications CSM
-
Exploiting Integrin-αVβ3 to Enhance Radiotherapy Efficacy in Medulloblastoma via Ferroptosis
Gotorbe C, Segui F, Echavidre W, Durivault J, Blanchard T, Vial V, Pagnuzzi-Boncompagni M, Villeneuve R, Amblard R, Garnier N, Ortholan C, Serrano B, Picco V, Pouyssegur J, Vucetic M, Montemagno C
Curr. Oncol. 31, 7390–7402 -
Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
Echavidre W, Durivault J, Gotorbe C, Blanchard T, Pagnuzzi M, Vial V, Raes F, Broisat A, Villeneuve R, Amblard R, Garnier N, Ortholan C, Faraggi M, Serrano B, Picco V, Montemagno C
Cancer Res Commun 3(12):2483-2496 -
Recent Pre-Clinical Advancements in Nuclear Medicine: Pioneering the Path to a Limitless Future
Echavidre W, Fagret D, Faraggi M, Picco V, Montemagno C
Cancers 15(19), 4839 -
Antiangiogenic Compound Axitinib Demonstrates Low Toxicity and Antitumoral Effects against Medulloblastoma
Pagnuzzi M, Picco V, Vial V, Planas-Bielsa V, Vandenberghe A, Daubon T, Derieppe M-A, Montemagno C, Durivault J, Grépin R, Martial S, Doyen J, Gavard J, Pagès G
Cancers 14(1) : 70 -
Integrin-αvβ3 as a Therapeutic Target in Glioblastoma: Back to the Future?
Echavidre W, Picco V, Faraggi M, Montemagno C
Pharm. 14(5) : 1053 -
Targeting of the ELR+CXCL/CXCR1/2 Pathway Is a Relevant Strategy for the Treatment of Paediatric Medulloblastomas
Penco-Campillo M, Molina C, Piris P, Soufi N, Carré M, Pagnuzzi M, Picco V, , Dufies M, Ronco C, Benhida R, Martial S, Pagès G
Cells 11(23), 3933 -
VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cells
Penco-Campillo M, Comoglio Y, Feliz Morel A J, Hanna R, Durivault J, Leloire M, Mejias B, Pagnuzzi M, Morot A, Burel-Vandenbos F, Selby M, Williamson D, Clifford S C, Claren A, Doyen J, Picco V, Martial S, Pagès G
Comm Biol 3(758): 579 -
Inhibition of the amino‐acid transporter LAT1 demonstrates anti‐neoplastic activity in medulloblastoma
Cormerais Y, Pagnuzzi M, Schrötter S, Giuliano S, Tambutté E, Endou H, Wempe M F, Pagès G, Pouyssegur J, Picco V
J Cell Mol Med 1-8 -
AKT1 restricts the invasive capacity of head and neck carcinoma cells harboring a constitutively active PI3 kinase activity
Brolih S, Parks S, Vial V, Durivault J, Mostosi L, Pouyssegur J, Pagès G, Picco V
BMC Cancer 18(1): 249 -
The c-Jun N-terminal kinase prevents oxidative stress induced by UV and thermal stresses in corals and human cells
Picco V, Courtial L, Grover R, Cormerais Y, Rottier C, Labbe A, Pagès G, Ferrier-Pagès C
Sci Rep 7: 45713 -
Validation of commercial ERK antibodies against the ERK orthologue of the scleractinian coral Stylophora pistillata
Picco V, Courtial L, Pagès G, Ferrier-Pagès C
F1000Res 6(577) -
ERK1/2/MAPK pathway-dependent regulation of the telomeric factor TRF2
Picco V, Coste I, Giraud-Panis M-J, Renno T, Gilson E, Pagès G
Oncotarget 7(29): 46615-46627 -
Telomeric repeat-binding factor 2: a marker for survival and anti-EGFR efficacy in oral carcinoma
Picco V, Benhamou Y, Raybaud H, Sudaka A, Chamorey E, Brolih S, Monteverde M, Merlano M, Nigro C L, Ambrosetti D, Pagès G
Oncotarget 7(28): 44236-44251 -
The telomere proteins in tumorigenesis and clinical outcomes of oral squamous cell carcinoma
Benhamou Y, Picco V, Pagès G
Adaptation and Evolution in Marine Environments 57: 46-53 -
Linking JNK Activity to the DNA Damage Response
Picco V, Pagès G
Genes Cancer 4(9-10): 360-368